Content and Copyright
-
- Add this to...
-
Twitter
-
Facebook
-
Google Bookmarks
-
LinkedIn
Population-based Laboratory Surveillance for AmpC β-Lactamase–producing Escherichia coli, Calgary
-
Published Date:Mar 2007
-
Source:Emerg Infect Dis. 13(3):443-448.
-
[PDF-215.34 KB]
Details:
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:In the Calgary Health Region during 2000-2003, prospective, active, population-based laboratory surveillance for all cefoxitin-resistant Escherichia coli isolates was performed. Isolates were screened with an inhibitor-based disk test, and plasmid-mediated types were identified by multiplex PCR with sequencing. A total of 369 AmpC beta-lactamase-producing E. coli isolates were identified; annual incidence rates were 1.7, 4.3, 11.2, and 15 per 100,000 residents for each year, respectively. AmpC beta-lactamase-producing E. coli was 5x more likely to be isolated from female than male patients across all age groups except < 1 year. Of these isolates, 83% were community onset, and urine was the principal site of isolation (90% of patients). PCR showed that 125 (34%) were positive for bla(cmy) genes; sequencing identified these enzymes to be CMY-2. In this large Canadian region, AmpC beta-lactamase-producing E. coli is an emerging community pathogen that commonly causes urinary tract infections in older women.
-
Subject:
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
-
Supporting Files:
text/plain 
image/gif 
image/jpeg 
image/gif 
image/jpeg 
image/gif 
image/jpeg
text/plain
No Related Documents.
You May Also Like:
-
Published Date:Source:Description:Public Access Available on: -
Published Date:Series:Description:File Type:[PDF - 99.97 KB]
-
Published Date:Series:Description:File Type:[PDF - 105.51 KB]
-
Published Date:Series:Description:File Type:[PDF - 118.56 KB]
-
Published Date:Series:Description:File Type:[PDF - 112.72 KB]